This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Tel Hashomer Medical Research Infrastructure and Services Ltd.. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Smadar Gertel: Innovator in Autoimmune Disease Treatment
Introduction
Smadar Gertel is a prominent inventor based in Herzeliya, Israel. She has made significant contributions to the field of medical research, particularly in the treatment of autoimmune diseases. Her innovative work has led to the development of synthetic peptides that hold promise for therapeutic applications.
Latest Patents
Smadar Gertel holds 1 patent for her invention titled "Synthetic peptides for the treatment of autoimmune diseases." This patent describes synthetic peptides that include a plurality of epitopes, each derived from different proteins, as well as peptides containing multiple citrullinated residues. The invention emphasizes the use of these peptides in treating autoimmune diseases and disorders.
Career Highlights
Gertel is associated with Tel Hashomer Medical Research Infrastructure and Services Ltd., where she continues to advance her research. Her work is characterized by a commitment to improving treatment options for patients suffering from autoimmune conditions.
Collaborations
Some of her notable coworkers include Yehuda Shoenfeld and Howard Amital, who are also recognized figures in the field of autoimmune disease research.
Conclusion
Smadar Gertel's innovative contributions to the treatment of autoimmune diseases through her patented synthetic peptides highlight her role as a leading inventor in medical research. Her work continues to inspire advancements in therapeutic strategies for complex health issues.